ABMD Financial Facts

Selling, general and administrative: 53.09M
Net loss: 8.88M
See Full Income Statement

Total liabilities and stockholders' equity: 474.9M
Accounts receivable, net: 46.61M
See Full Balance Sheet

Abiomed Inc. (ABMD) Earnings

  |   Expand Research on ABMD
Next EPS Date 2/3/17 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +22.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -5.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/27/16 Q217 $0.20$0.24 -$0.04$103M$103.16M = Details
7/28/16 Q117 $0.29$0.23 +$0.06$103M$97.23M = Details
5/3/16 Q416 $0.24$0.19 +$0.05$94M$90.52M = Details
2/4/16 Q316 $0.23$0.15 +$0.08$85.8M$80.04M N/A Details
8/4/15 Q116 $0.20$0.08 +$0.12$73.4M$66.27M N/A Details
5/5/15 Q415 $2.24$0.14 +$2.10$67.6M$62.55M N/A Details
1/28/15 Q315 $0.30$0.04 +$0.26$62M$53.2M Details
10/30/14 Q215 $0.03$0.02 +$0.01$51.8M$48.8M Details